Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Cortical Perfusion Alteration in Normal-Appearing Gray Matter Is Most Sensitive to Disease Progression in Relapsing-Remitting Multiple Sclerosis.
Cost-effectiveness of fingolimod versus interferon beta-1a for relapsing remitting multiple sclerosis in the United States.
Structural Brain MR Imaging Changes Associated with Obsessive-Compulsive Disorder in Patients with Multiple Sclerosis.
One of the oldest patients with Neuromyelitis Optica in the literature.
Bevacizumab Diminishes Experimental Autoimmune Encephalomyelitis by Inhibiting Spinal Cord Angiogenesis and Reducing Peripheral T-Cell Responses.
Matrix metalloproteinase-2 and -9 as promising benefactors in development, plasticity and repair of the nervous system.
Season of birth as a risk factor for multiple sclerosis in Brazil.
Induction of pluripotent stem cells from adult human fibroblasts by defined factors.
Helicobacter pylori and neurological diseases: Married by the laws of inflammation.
Neutralizing antibodies and fatigue as predictors of low response to interferon-beta treatment in patients with multiple sclerosis.
Metabolic Control of Th17 Cell Generation and CNS Inflammation.
A small molecule binding HMGB1 and HMGB2 inhibits microglia-mediated neuroinflammation.
Sleep and oligodendrocyte functions.
Relationship of UV exposure to prevalence of multiple sclerosis in England.
The CSF JCV antibody index for diagnosis of natalizumab-associated PML.
Glutathione in multiple sclerosis: More than just an antioxidant?
Minocycline down-regulates MHC II expression in microglia and macrophages through inhibition of IRF-1 and protein kinase C (PKC)alpha/betaII.
Treatment of NMO relapse in the elderly: rituximab when plasma exchange fails?
Neuro-ophthalmologic evaluation, quality of life, and functional disability in patients with MS.
The Role of ATP-Binding Cassette Transporters in Neuro-Inflammation: Relevance for Bioactive Lipids.
Genetic inactivation of the adenosine A(2A) receptor exacerbates brain damage in mice with experimental autoimmune encephalomyelitis.
Comparison of Standard 1.5 T vs. 3 T Optimized Protocols in Patients Treated with Glatiramer Acetate. A Serial MRI Pilot Study.
Determinants of central nervous system adult neurogenesis are sex, hormones, mouse strain, age, and brain region.
Resting State Brain Entropy Alterations in Relapsing Remitting Multiple Sclerosis.
Fingolimod in a patient with heart failure on the background of pulmonary arterial hypertension and coronary artery disease.
Pages
« first
‹ previous
…
264
265
266
267
268
269
270
271
272
…
next ›
last »